Biosensors International Group, Ltd

Biosensors International Group, Ltd is dedicated to saving lives through innovation in the medical device industry. Biosensors International specializes in developing, manufacturing, and marketing pioneering interventional cardiology devices, including the BioMatrix™ DES family, featuring Biolimus A9™ (BA9™) for cardiovascular stent technologies. The company’s commitment extends to providing high-quality medical devices that significantly improve patient outcomes.

Biosensors International Group, Ltd continues to invest in groundbreaking medical technology, supported by robust clinical data and the engineering of new medical devices that further benefit patients. The company's products include BioMatrix Alpha™, a CoCr stent with an innovative hybrid design, and BioFreedom™, which has demonstrated superior safety and efficacy in high bleeding risk patients. These advancements underscore Biosensors' dedication to pushing the boundaries of medical innovation.

With a global presence, Biosensors International Group, Ltd operates from multiple locations, including its primary address at 36, Jalan Tukang, Singapore, 619266, SG, as well as Rue de Lausanne 29, Morges, 1110, CH; NBF Hibiya Bldg. 1-1-7, Uchisaiwaicho, Chiyoda-ku, Tokyo, 100-0011, JP; Arnoudstraat 8, Hillegom, 2182 DZ, NL; Jalan Tanah Abang II No. 67, Jakarta Pusat, 10160, ID; and 68 Dalian Road, Weihai, Shandong 264209, CN. Biosensors International and its dedicated team are at the forefront of transforming cardiovascular and structural heart technologies. We invite the manager of Biosensors International Group, Ltd to create a customized and exclusive company showcase and product listing on our platform.